Encompass Health Co. (NYSE:EHC) Insider Sells $850,200.00 in Stock

Encompass Health Co. (NYSE:EHC) insider Elissa Joy Charbonneau sold 10,000 shares of Encompass Health stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $85.02, for a total transaction of $850,200.00. Following the completion of the transaction, the insider now directly owns 18,594 shares of the company’s stock, valued at approximately $1,580,861.88. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Encompass Health Stock Down 0.1 %

NYSE EHC opened at $84.49 on Monday. The company has a current ratio of 1.37, a quick ratio of 1.37 and a debt-to-equity ratio of 1.14. The company has a market cap of $8.51 billion, a price-to-earnings ratio of 22.84, a PEG ratio of 1.32 and a beta of 0.92. The company has a 50 day moving average of $82.21 and a 200-day moving average of $74.07. Encompass Health Co. has a 1-year low of $57.55 and a 1-year high of $87.94.

Encompass Health (NYSE:EHC) last released its earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $0.93 by $0.19. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The firm had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.27 billion. During the same period in the prior year, the company posted $0.88 EPS. The company’s revenue was up 13.4% compared to the same quarter last year. On average, equities research analysts expect that Encompass Health Co. will post 4.1 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Stockholders of record on Monday, July 1st will be given a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.71%. The ex-dividend date of this dividend is Friday, June 28th. Encompass Health’s payout ratio is presently 16.22%.

Analyst Ratings Changes

A number of equities analysts have weighed in on EHC shares. Truist Financial boosted their price target on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research report on Friday, February 9th. Raymond James restated a “strong-buy” rating and issued a $95.00 price target (up previously from $85.00) on shares of Encompass Health in a research note on Friday, April 26th. Barclays lifted their price objective on shares of Encompass Health from $101.00 to $108.00 and gave the stock an “overweight” rating in a research report on Thursday, April 25th. Mizuho increased their price objective on shares of Encompass Health from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Thursday, April 25th. Finally, William Blair reiterated an “outperform” rating on shares of Encompass Health in a research note on Wednesday, February 7th. Eight analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Encompass Health has a consensus rating of “Buy” and a consensus price target of $92.00.

Institutional Trading of Encompass Health

Several large investors have recently made changes to their positions in the company. International Assets Investment Management LLC acquired a new stake in shares of Encompass Health in the 4th quarter valued at $20,210,000. Jackson Creek Investment Advisors LLC boosted its stake in Encompass Health by 364.4% in the fourth quarter. Jackson Creek Investment Advisors LLC now owns 13,910 shares of the company’s stock valued at $928,000 after buying an additional 10,915 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. grew its position in Encompass Health by 2.3% in the fourth quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,318,784 shares of the company’s stock valued at $87,989,000 after acquiring an additional 29,926 shares during the last quarter. Phocas Financial Corp. raised its stake in Encompass Health by 112.4% during the fourth quarter. Phocas Financial Corp. now owns 99,875 shares of the company’s stock worth $6,664,000 after acquiring an additional 52,847 shares in the last quarter. Finally, TimesSquare Capital Management LLC boosted its stake in shares of Encompass Health by 18.1% in the 4th quarter. TimesSquare Capital Management LLC now owns 1,150,866 shares of the company’s stock valued at $76,786,000 after purchasing an additional 175,975 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.